1. health and fitness

According to the latest market report published by Persistence Market Research titled
“Global Market Study on Western Blotting: Increasing Prevalence of HIV and
Spontaneous Research in the Field of Proteomics Fuelling the Growth of Western
Blotting”, the western blotting market is expected to be valued at US$ 529.1 Mn by
the end of 2015. It is anticipated to expand at a CAGR of 5.4% during the forecast
period (2015–2021) to account for US$ 725.0 Mn by 2021.
Western blotting technique is considered the gold standard for the diagnosis of HIV.
Western blotting, due to its high specificity and reproducibility, is used as a
confirmatory test for the diagnosis of HIV. According to the World Health
Organization (WHO), it is estimated that in 2013, only 51% of the people with HIV
knew about their syndrome status. A major reason for low diagnosis of HIV is the
fear amongst the population of getting positively diagnosed with HIV and
confidentiality issues related to testing results. As per the statistics released by the
joint United Nations program on HIV/AIDS, in 2013, around 35.2 Mn HIV cases
were recorded with two million new cases being detected in 2014, taking the
combined total for both years to 37.2 Mn. Wide application of western blotting
technique in various fields such as scientific research, medical diagnostics, food &
beverages industry, agricultural, and other applications is fueling the growth of the
western blotting market globally.
Request to view table of content @
https://www.persistencemarketresearch.com/toc/3044
The growth of the western blotting market is mainly driven by rising incidence of
HIV, increasing usage of western blotting in the field of proteomics, and rising
demand for advancements and innovation in drug development. However, factors
such as inadequate funding in developing countries, high pricing of products, and
non-availability of devices in developing countries are expected to hamper overall
market growth.
The western blotting market is segmented on the basis of product, application, region,
and end user. North America dominated the western blotting market with over 30%
share and is expected to remain dominant throughout the forecast period. Revenue
from western blotting markets in Asia and Latin America are expected to expand at
CAGRs of 6.2% and 6.0% respectively during the forecast period.
Request Sample Report @
https://www.persistencemarketresearch.com/samples/3044
In terms of volume growth, reagent kits segment is expected to account for maximum
share over the forecast period. Electrophoresis blotting systems segment is expected
to register higher CAGR as compared to other segments in terms of volume.
As western blotting is a time consuming and labor intensive process, end users are
opting for automated blotting systems to address these issues. The manual technique
demands continuous supervision, hence manpower is mandatory while performing
this method to enhance reproducibility. Automated systems perform steps such as
mixing of the solution, washing of gel, and hence reduces the time required for
completion of the protocol. However, the debate regarding the trustworthiness of this
technique continues across the healthcare sector, as the outcomes of tests vary
according to the methodology adopted to complete the process. Selection of proper
substrate and antibody is a must to achieve desired results due to the specificity of the
test.
Key market players covered in this report include Thermo Fisher Scientific, Inc., GE
Healthcare, Hoffmann-La Roche Ltd., Danaher Corporation (Lumigen, Inc.), EMD
Millipore Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., LI-COR, Inc.,
Bio-Techne Corporation (ProteinSimple Inc.), and Advansta, Inc. These players have
been profiled on the basis of various attributes such as company overview, recent
developments, growth strategies, sustainability, and financial overview.
Buy Western Blotting Market Report @
https://www.persistencemarketresearch.com/checkout/3044
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research
model is a unique collaboration of data analytics and market research methodology to
help businesses achieve optimal performance. To support companies in overcoming
complex business challenges, we follow a multi-disciplinary approach. At PMR, we
unite various data streams from multi-dimensional sources. By deploying real-time
data collection, big data, and customer experience analytics, we deliver business
intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com